Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Move more, not just exercise: study tests heart benefits for overweight women

NCT ID NCT06270810

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether increasing everyday physical activities (like walking or housework) along with aerobic exercise improves heart health more than exercise alone in overweight young women. Twenty-eight women were split into two groups: one did only moderate aerobic exercise, the other added more daily movement. Researchers measured cholesterol, blood pressure, and other heart-related markers to compare the effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Mar 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * To have a body mass index between 25 kg.(m2)-1 and 29.9 kg.(m2)-1 * Self reported sitting time greater than 7 hours per day * Not exercising regularly in the last 3 months Exclusion Criteria: * Hypertension * Coronary heart disease * Heart failure * Diabetes mellitus (A1C being 6.5% and above) * Prediabetes (A1C between 5.7% and 6.4%) * Metabolic syndrome * Hypothyroidism * Non-alcoholic fatty liver disease * Chronic inflammatory disease * Chronic renal failure * Cushing's syndrome * Musculoskeletal disorder that will affect the ability to do physical activity * HIV infection * Being on antihypertensive medication * Being on lipid-lowering medication * Being on antidiabetic medication * Being on systemic glucocorticoid medication * Smoking * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kastamonu University, Çatalzeytin Vocational School

    Çatalzeytin, Kastamonu, 37, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.